Fresenius Kabi is a leading global healthcare company specializing in life-saving medicines and medical technologies for infusion, transfusion and clinical nutrition. Our mission is to improve access to quality healthcare and enrich the lives of critically and chronically ill patients. With over 43,000 employees and sales of over 8 billion euros in 2023, we drive innovation and provide world-class solutions in biopharmaceuticals, clinical nutrition and medical technology.
As part of our "Vision 2026", we want to achieve efficiency gains in therapy and patient care worldwide and further expand our leading position in our sectors.
In the position of Manager Financial Disclosures & Analytics, you will play a central role in analyzing and interpreting the financial performance indicators of the Fresenius Kabi Group and thus make an important contribution to strategic decisions. Your main tasks include:
You are an analytical, solution-oriented person with a keen sense of numbers and systems. You also have the following qualifications:
At Fresenius Kabi, we offer you more than just a position - we offer you long-term career prospects in a dynamic, global company that is constantly evolving. Our inclusive culture emphasizes innovation, respect and collaboration. You will benefit from the flexibility to work remotely up to three days a week and have the chance to lead groundbreaking international projects. Seize the opportunity to drive meaningful change and contribute to the future of global healthcare.
As long as the job ad is online, you can apply quickly and easily.
At Fresenius all job applicants are welcome – regardless of gender, age, origin, nationality, religion, disability, sexual identity and orientation, or any other personal characteristics.
All terms used in this job advertisement to denote persons refer to all genders equally (male, female, diverse).
When it’s not just a job, but your calling. When you have an impact on people’s lives every day. When you can’t imagine doing something else. Then you know it’s Fresenius.